Dashboard
Manage Tickers

COYA


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

coya-therapeutics-spokesperson-tells-benzinga-david-einhorn-owns-approximately-99-of-coya-therapeutics-and-included-us-in-his-annual-shareholder-letter-today
Coya Therapeutics Spokesperson Tells Benzi...
10/14/2025 17:28:09

watching-coya-therapeutics-shares-see-volume-to-the-upside-traders-circulate-greenlight-capital-has-a-new-undisclosed-position-in-the-co-writes-3-paragraphs-about-it-in-its-quarterly-investor-letter-believing-it-has-a-chance-to-receive-fast-track-fda-approval
Watching Coya Therapeutics; Shares See Vol...
10/14/2025 14:52:50

btig-reiterates-buy-on-coya-therapeutics-maintains-15-price-target
BTIG Reiterates Buy on Coya Therapeutics, ...
09/30/2025 11:56:50

BTIG analyst Thomas Shrader reiterates Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $15 price target.

d-boral-capital-maintains-buy-on-coya-therapeutics-maintains-18-price-target
D. Boral Capital Maintains Buy on Coya The...
09/29/2025 13:48:38

D. Boral Capital analyst Jason Kolbert maintains Coya Therapeutics (NASDAQ: COYA) with a Buy and maintains $18 price target.

coya-therapeutics-completes-patient-enrollment-of-investigator-initiated-open-label-study-with-low-dose-il-2-and-ctla4-ig-combination-treatment-in-patients-with-mild-to-moderate-frontotemporal-dementia
Coya Therapeutics Completes Patient Enroll...
09/29/2025 12:20:45

Following the positive interim results in 5 patients announced earlier this year, a total of 9 patients have been enrolled as p...

d-boral-capital-maintains-buy-on-coya-therapeutics-maintains-18-price-target
D. Boral Capital Maintains Buy on Coya The...
09/22/2025 14:09:02

D. Boral Capital analyst Jason Kolbert maintains Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $18 price target.

coya-therapeutics-launches-phase-2-alstars-trial-of-coya-302-for-als-across-25-sites-in-us-and-canada
Coya Therapeutics Launches Phase 2 ALSTARS...
09/22/2025 12:11:10

The ALSTARS Trial is a well powered randomized, multi-center, double-blind, placebo-controlled, 24-week  study of COYA 302 in p...

d-boral-capital-maintains-buy-on-coya-therapeutics-maintains-18-price-target
D. Boral Capital Maintains Buy on Coya The...
09/17/2025 11:43:02

D. Boral Capital analyst Jason Kolbert maintains Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $18 price target.

d-boral-capital-maintains-buy-on-coya-therapeutics-maintains-18-price-target
D. Boral Capital Maintains Buy on Coya The...
09/04/2025 13:33:51

D. Boral Capital analyst Jason Kolbert maintains Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $18 price target.

coya-therapeutics-upcoming-phase-2-clinical-trial-to-evaluate-efficacy-and-safety-of-coya-302-in-patients-with-als-accepted-as-neals-affiliated-trial-by-neals-consortium
Coya Therapeutics' Upcoming Phase 2 Clinic...
09/04/2025 12:14:04

NEALS, the world's largest ALS research consortium, has selected the COYA 302 trial and it is now affiliated with NEALS as ...

hc-wainwright--co-reiterates-buy-on-coya-therapeutics-maintains-18-price-target
HC Wainwright & Co. Reiterates Buy on Coya...
08/27/2025 11:18:51

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $18 p...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
08/25/2025 21:07:30

whats-going-on-with-coya-therapeutics-stock
What's Going On With Coya Therapeutics Stock?
08/25/2025 13:57:20

Shares of Coya Therapeutics are trading higher Monday morning. The company provided an update regarding the development of a ne...

d-boral-capital-maintains-buy-on-coya-therapeutics-maintains-18-price-target
D. Boral Capital Maintains Buy on Coya The...
08/25/2025 12:52:37

D. Boral Capital analyst Jason Kolbert maintains Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $18 price target.

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
08/25/2025 12:08:04

coya-therapeutics-announces-fda-acceptance-of-investigational-new-drug-application-for-coya-302-in-als
Coya Therapeutics Announces FDA Acceptance...
08/25/2025 12:04:02

hc-wainwright--co-reiterates-buy-on-coya-therapeutics-maintains-18-price-target
HC Wainwright & Co. Reiterates Buy on Coya...
08/25/2025 11:25:17

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $18 p...

d-boral-capital-maintains-buy-on-coya-therapeutics-maintains-18-price-target
D. Boral Capital Maintains Buy on Coya The...
08/13/2025 16:10:10

D. Boral Capital analyst Jason Kolbert maintains Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $18 price target.

chardan-capital-maintains-buy-on-coya-therapeutics-maintains-14-price-target
Chardan Capital Maintains Buy on Coya Ther...
08/13/2025 14:28:21

Chardan Capital analyst Keay Nakae maintains Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $14 price target.

coya-therapeutics-q2-eps-036-beats-042-estimate-sales-163616k-miss-940000k-estimate
Coya Therapeutics Q2 EPS $(0.36) Beats $(0...
08/12/2025 12:05:54

Coya Therapeutics (NASDAQ:COYA) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION